Sergey Jakimov

Sergey Jakimov is a founding partner of LongeVC, a venture capital company supporting early-stage biotech and longevity-focused founders that are changing the world. Sergey is a serial entrepreneur, having raised more than $50 million in venture funding for his own ventures. He has advised several other startups in the therapeutics space on fundraising, IP protection, and clinical trial strategies. He is also a Visiting Lecturer to several universities on venture capital and intellectual property rights and co-authored a master’s program in Technology Law for the Riga Graduate School of Law. Since 2018, he has led medical tech startup Longenesis, a cutting-edge company that unlocks the hidden value of biomedical data and accelerates novel drug treatment & discovery. Sergey holds a BSc in International Affairs from Rīga Stradiņš University and two MSc in Political Science and Government and Law and Finance from Central European University and Riga Graduate School of Law, respectively. He was named as a Forbes Latvia 30 Under 30 in technology and healthcare in 2020.